Sublingual Microcirculation and Postoperative Ileus
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01828047 |
Recruitment Status :
Completed
First Posted : April 10, 2013
Last Update Posted : March 17, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Colorectal Cancer Inflammatory Bowel Diseases Gastrointestinal Dysfunction | Device: orthogonal polarization spectral (OPS) imaging |
AIM OF THE STUDY This observational study will assess whether perioperative microcirculatory changes can be correlated with symptoms associated with primary POI.
PRIMARY RESEARCH QUESTION Is there a correlation between peri-operative microcirculatory flow measurements and the incidence of symptomatic primary POI?
SECONDARY RESEARCH QUESTIONS
- Is there a correlation between peri-operative microcirculatory flow measurements and the duration of symptomatic primary POI?
- If any correlation is observed, which anatomic location (sublingual mucosa vs bowel serosa) yields microcirculatory flow measurements that are more strongly associated with the incidence and/or duration of symptomatic primary POI?
- Can either intraoperative sublingual mucosa or intraoperative bowel serosa microcirculatory flow measurements predict symptoms of primary POI? Are these two anatomic locations equivalent in their ability to predict this complication?
Study Type : | Observational |
Actual Enrollment : | 34 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Correlation Between Sublingual Microcirculation and Postoperative Ileus Symptoms in Patients Undergoing Colorectal Surgery - a Pilot Study |
Study Start Date : | November 2013 |
Actual Primary Completion Date : | November 2014 |
Actual Study Completion Date : | November 2014 |
Group/Cohort | Intervention/treatment |
---|---|
Elective colorectal surgeries
Patients undergoing elective colorectal procedures with an Enhanced Recovery Program. Orthogonal polarization spectral (OPS) imaging will be used to measure sublingual microcirculation
|
Device: orthogonal polarization spectral (OPS) imaging
orthogonal polarization spectral (OPS) imaging allows noninvasive observation of human microcirculation in all accessible tissue surfaces |
- Postoperative ileus symptoms; microvascular flow index (MFI) [ Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days ]
Patients will be considered having POI symptoms if at least one symptom, for each of the following criteria, will be reported:
i. Vomiting (+/- nausea) OR abdominal distension AND ii. Absence of passing gas/stool OR not tolerating oral diet.
Microvascular flow index (MFI) score: this score is based on determination of the predominant type of flow observed. Flow is characterized as absent (0), intermittent (1), sluggish (2), or normal (3).

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Patients older than 18 yo undergoing elective laparoscopic colorectal surgery with an Enhanced Recovery Program (ERP) at the Montreal General Hospital
Exclusion Criteria:
- Any patient who refuses enrolment

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01828047
Canada, Quebec | |
Montreal General Hospital | |
Montreal, Quebec, Canada, H3G 1A4 |
Principal Investigator: | Gabriele Baldini, MD, MSc | McGill University |
Responsible Party: | Gabriele Baldini, MD, MSc, Assistant Professor, Assitant Professor, McGill University Health Centre/Research Institute of the McGill University Health Centre |
ClinicalTrials.gov Identifier: | NCT01828047 |
Other Study ID Numbers: |
12-214-SDR |
First Posted: | April 10, 2013 Key Record Dates |
Last Update Posted: | March 17, 2015 |
Last Verified: | March 2015 |
Inflammatory Bowel Diseases Digestive System Diseases Gastrointestinal Diseases Intestinal Diseases Gastroenteritis |